Company Announcements

Holding(s) in Company

Source: RNS
RNS Number : 5586X
JPMorgan American IT PLC
02 May 2019
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

JPMorgan American Investment Trust plc  

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

YES

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:
iii

Chase Nominees Limited

4. Full name of shareholder(s)
 (if different from 3.):iv

Chase Nominees Limited

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

2nd May 2019

6. Date on which issuer notified:

2nd May 2019

7. Threshold(s) that is/are crossed or
reached:
vi, vii

3%

           
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBP 0.05

7,842,850

7,842,850

7,842,850

 

0

 

0.00%

GB00BKZGVH64

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

0

0.00%

                                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Chase Nominees Limited announces that J.P. Morgan Trustee & Administration Services Limited no longer has a notifiable interest in 7,842,850 Ordinary shares. These shares are held on behalf of participants in the JPMorgan investment trust savings products.  J.P. Morgan Trustee & Administration Services Limited has a notifiable interest in these shares because, in certain circumstances and subject to certain limitations agreed with the Takeover Panel to ensure compliance with the Takeover Code, JPMorgan is entitled to exercise the voting rights attached to the Ordinary shares if the relevant plan participants do not do so.

 

JPMorgan was entitled to exercise the voting rights attached to these Ordinary shares in relation to the Company's Annual General Meeting held on Thursday 2nd May 2019.  This entitlement has now ceased following the conclusion of the 2019 Annual General Meeting.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A

 


13. Additional information:

N/A

14. Contact name:

Alison Vincent

15. Contact telephone number:

020 7742 4000

     

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUROKRKOASORR